Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
PLoS Med
; 19(2): e1003897, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-35113855
Full text:
1
Database:
MEDLINE
Main subject:
Receptors, Adrenergic, beta-1
/
Peptidyl-Dipeptidase A
/
Mendelian Randomization Analysis
/
Neoplasms
/
Antihypertensive Agents
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
PLoS Med
Journal subject:
MEDICINA
Year:
2022
Type:
Article
Affiliation country:
United kingdom